Myriad Genetics, Inc. (MYGN-NASDAQ) has issued a press release discussing a new study showing that the potential savings to the US healthcare system alone could be $4.0 Trillion from 2010 to 2050. It estimates…
Mylan Labs (MYL-NYSE) is seeing its shares take a beating because it is acquiring Merck KGaA’s generic unit and Mylan is the acquirer in what is a very leveraged buyout. It isn’t just the…
by H.S. AyoubBioHealth Investor.com Biotechnology DENDREON CORP +10.29% NORTHFIELD LABS IN +10.25% COMBINATORX +9.56% ONYX PHARM INC +8.70% SEQUENOM INC +8.08% Diagnostic Substances ICAGEN, INC. +8.00% MONOGRAM BIOSCIENCES +5.00% HEALTHCARE TECH LTD +4.50% LEXICON…
From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s Business Daily (5/12/07) scores out of 100 (last week’s rank, change…
Dendreon hosted a painful conference call today, and despite management answering most questions you could hear some frustration and disappointment out of management. The FDA has requested additional data but not specified what form…
Dendreon (DNDN-NASDAQ) has already been noted as a bust this morning by us and by everyone else. Even the Sub-Saharan Africa nations have noticed it, and this 10-point drop in the stock may force…
Dendreon (DNDN-NASDAQ) has only up to 4 full trading before that May 15 FDA review date. The funny thing here is that the options have actually become more expensive since reporting on this last…
by H.S. AyoubBioHealth Investor.com
Johnson & Johnson’s (JNJ) new drug coated stent did not cut it. The experimental drug-coated stent failed to meet its primary goal in a study, according to Reuters. "The CoStar stent is one of…
By Yaser Anwar, CSC of Equity Investment Ideas
by H.S. AyoubBioHealth Investor.com
Novavax Inc. (NVAX-NASDAQ) is up 8.5% in pre-market stock trading on positive data coming out of its pandemic flu studies. This is not being studied on humans, as ferrets are the inoculation group. Ferrets…
IBM (IBM-NYSE) is using nanotechnology in new chips, well sort of. The company is essentially boring holes with a width of 20 nanometers to run faster and use less energy. It is also claiming…
by H.S. AyoubBioHealth Investor.com
A.G.Edwards has initiated the recently volatile and controversial Dendreon (DNDN-NASDAQ) with a Hold/Speculative rating. The summary points are that it is starting the biotech as a Hold rated stock for Speculative investors. It sees…